Nevertheless, a non-significant trend towards lower thromboembolic risk in the edoxaban group was identified, but it did not reach statistical significance (HR 0.65 [CI 0.39–1.07]).
← all excerpts
Refining Stroke Risk Assessment in Patients with Device-Detected Atrial Fibrillation.
1
—
—